Physician

Ashvin K Shah, M.D.

According to 2025 Medicare claims, Ashvin Shah, M.D. (NPI: 1013015270) practices pulmonary disease in the Yuma, AZ market, with the plurality of this provider's patient population coming from Yuma, AZ. This provider's primary affiliated billing organization is ALERACARE AIC LLC (NPI: 1124735063; TIN: 884050378) and primary practice location at 85364-8878. Shah is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 656 traditional Medicare patients, billed 64,479 HCPCS/CPT codes, and received $1,598,598 in Medicare payments. The top billing code was 95810 (Sleep study in sleep lab (6 years or older)). Part D data shows 514 prescription claims across 113 beneficiaries totaling $378,777 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 9,589 claims. Open Payments data shows 37 records totaling $33,304. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $442,710 to $1,598,598. Similarly, Part D prescription costs have risen steadily, from $55,026 to $378,777. For DME billing, reported payments rose steadily, from $318,471 to $360,570.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,019	3,307	$442,710
2016	834	2,346	$297,206
2017	1,243	3,471	$438,654
2018	1,259	4,046	$441,666
2019	1,612	10,642	$861,350
2020	1,192	21,249	$1,600,914
2021	971	24,044	$1,800,122
2022	587	24,318	$1,264,197
2023	535	18,990	$534,706
2024	656	64,479	$1,598,598

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	81	412	$55,026
2016	84	428	$69,879
2017	71	316	$50,035
2018	127	424	$125,167
2019	177	748	$378,338
2020	167	770	$409,302
2021	141	710	$671,111
2022	146	656	$665,994
2023	113	573	$554,226
2024	113	514	$378,777

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,508	5,500	$338,578
2016	2,737	6,479	$239,684
2017	3,382	7,889	$207,486
2018	4,214	9,693	$252,741
2019	4,767	11,511	$331,303
2020	4,748	11,570	$434,881
2021	4,192	9,863	$407,146
2022	4,089	9,419	$390,263
2023	3,952	9,946	$442,689
2024	4,001	9,589	$389,367

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95810	Sleep study in sleep lab (6 years or older)	141	142	$464
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	162	162	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	334	557	$92
94060	Test to measure expiratory airflow and volume changes before and after medication administration	91	91	$30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	195	246	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	12	360	$160,447
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	120	6,570	$132,942
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	1,380	$20,037
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	12	360	$5,377
Wixela Inhub	Fluticasone Propion/Salmeterol	12	900	$4,383

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7030	Full face mask used with positive airway pressure device, each	N	276	559	$44,647
E0601	Continuous positive airway pressure (cpap) device	Y	232	1,245	$40,771
A7031	Face mask interface, replacement for full face mask, each	N	228	546	$40,544
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	32	$32,559
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	325	622	$31,950

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$956	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$32,348	SANOFI US SERVICES INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashvin K. Shah, M.D.?

Tedicare shows public-source Medicare data for Ashvin K. Shah, M.D. (NPI 1013015270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashvin K. Shah, M.D. have ACO affiliation data?

Ashvin K. Shah, M.D. is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Ashvin K. Shah, M.D.?

Ashvin K. Shah, M.D. is linked to ALERACARE AIC LLC (billing NPI 1124735063) in the available physician profile data.

Does Ashvin K. Shah, M.D. have Open Payments data?

Ashvin K. Shah, M.D. has 37 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.